Results 91 to 100 of about 346 (122)

Kaposiform Lymphangiomatosis, a Newly Characterized Vascular Anomaly Presenting with Hemoptysis in an Adult Woman

Annals of the American Thoracic Society, 2013
Disorders of the pulmonary lymphatic system include macro- and microcystic lymphatic malformations, primary or secondary lymphangiectasias, generalized lymphatic anomalies, diffuse pulmonary lymphangiomatosis, and combinations of lymphatic and other tissue anomalies, including lymphangioleiomyomatosis (LAM).
Fadi, Safi, Anita, Gupta, Denise, Adams, Vasuki, Anandan, Francis X, McCormack, Ragheb, Assaly   +5 more
openaire   +2 more sources

Splenic Lesions and Other Findings in Kaposiform Lymphangiomatosis

American Journal of Surgical Pathology, 2023
Dimas, Suárez-Vilela, Francisco M, Izquierdo, Emiliano, Honrado, Cristina, Díez-Tascón   +3 more
openaire   +2 more sources

[Clinical characteristics of Kaposiform lymphangiomatosis: a report of 8 cases].

Zhonghua wai ke za zhi [Chinese journal of surgery], 2019
Objective: To investigate the clinical symptoms, treatment intervention and prognosis of Kaposiform lymphangiomatosis(KLA). Methods: Medical information and clinical characteristics data of 8 KLA patients who were admitted to Department of Pediatric Surgery of West China Hospital of Sichuan University from January 2016 to February 2019 were ...
T, Qiu, K Y, Yang, S H, Peng, S Y, Dai, S Y, Chen, Y, Ji   +5 more
openaire   +1 more source

Kaposiform Lymphangiomatosis with Human Papillomavirus Infection

American Journal of Respiratory and Critical Care Medicine, 2017
Elżbieta Radzikowska, Katarzyna Błasińska-Przerwa, Małgorzata Szołkowska, Agnieszka Miąsko, Włodzimierz Kupis, Elżbieta Wiatr   +5 more
openaire   +2 more sources

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce, Lorenzo Cohen, Karen M Mustian   +2 more
exaly  

Reply to: Comment on: Potential biomarkers of kaposiform lymphangiomatosis

Pediatric Blood & Cancer, 2020
Michio Ozeki, Toshiyuki Fukao
openaire   +2 more sources

Kaposiform lymphangiomatosis in adult patients– results of sirolimus treatment

Clinical problems, 2021
Elżbieta Radzikowska, Katarzyna Błasińska, Małgorzata Szolkowska, Elzbieta Wiatr   +3 more
openaire   +1 more source

Regression of kaposiform lymphangiomatosis and chronic disseminated intravascular coagulation after inhaled budesonide-formoterol treatment

Pediatric Blood & Cancer, 2023
Masaru Imamura, Chansu Shin, Michio Ozeki, Kentaro Matsuoka, Akihiko Saitoh, Chihaya Imai   +5 more
openaire   +2 more sources

Chest imaging in generalized lymphatic anomaly and kaposiform lymphangiomatosis

Pediatrics International, 2018
Hiroki Kato, Michio Ozeki, Toshiyuki Fukao, Masayuki Matsuo   +3 more
openaire   +2 more sources

A high-throughput zebrafish screen identifies novel candidate treatments for Kaposiform Lymphangiomatosis (KLA)

AbstractKaposiform Lymphangiomatosis (KLA) is a rare, aggressive, and incurable disease caused by a somatic activating NRAS mutation (p.Q61R) in lymphatic endothelial cells (LECs). The development of new therapeutic avenues is hampered by the lack of animal models faithfully replicating the clinical manifestations of KLA.
Ivan Bassi, Amani Jabali, Naama Farag, Shany Egozi, Noga Moshe, Gil S. Leichner, Polina Geva, Lotan Levin, Aviv Barzilai, Camila Avivi, Jonathan Long, Jason J. Otterstrom, Yael Paran, Haim Barr, Karina Yaniv, Shoshana Greenberger   +15 more
openaire   +1 more source